• LAST PRICE
    1.8350
  • TODAY'S CHANGE (%)
    Trending Up0.0350 (1.9444%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    1.8500 / 1.8000
  • Day Range
    Low 1.8000
    High 1.8500
  • 52 Week Range
    Low 0.3900
    High 18.0000
  • Volume
    3,369
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.8
TimeVolumeARTH
09:35 ET1001.85
10:42 ET10001.8
11:14 ET1001.85
11:27 ET5001.8425
01:04 ET15001.81
02:23 ET1001.835
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesARTH
Arch Therapeutics Inc
8.5M
-0.4x
---
United StatesDROR
Dror Ortho-Design Inc
8.8M
-3.6x
---
United StatesSIGYD
Sigyn Therapeutics Inc
6.4M
-1.4x
---
United StatesSTSS
Sharps Technology Inc
5.5M
-0.5x
---
United StatesACUT
Accustem Sciences Inc
5.1M
-1.8x
---
United StatesLUCY
Innovative Eyewear Inc
5.0M
-0.5x
---
As of 2024-02-24

Company Information

Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.

Contact Information

Headquarters
235 Walnut St Ste 6FRAMINGHAM, MA, United States 01702-7504
Phone
617-431-2313
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
Terrence Norchi
Chief Financial Officer, Treasurer
Michael Abrams
Vice President - Sales
Shawn Carlson
Independent Director
Punit Dhillon
Independent Director
Guy Fish

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$8.5M
Revenue (TTM)
$75.7K
Shares Outstanding
4.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
3.57
EPS
$-4.94
Book Value
$-1.60
P/E Ratio
-0.4x
Price/Sales (TTM)
112.7
Price/Cash Flow (TTM)
---
Operating Margin
-6,662.03%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.